Your browser is no longer supported. Please, upgrade your browser.
ENTL Entellus Medical, Inc. daily Stock Chart
ENTL [NASD]
Entellus Medical, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own2.40% Shs Outstand17.00M Perf Week1.15%
Market Cap418.71M Forward P/E- EPS next Y-1.31 Insider Trans-31.02% Shs Float- Perf Month51.01%
Income-26.90M PEG- EPS next Q-0.44 Inst Own91.70% Short Float- Perf Quarter42.21%
Sales86.20M P/S4.86 EPS this Y-43.50% Inst Trans16.45% Short Ratio7.16 Perf Half Y72.72%
Book/sh4.98 P/B4.95 EPS next Y9.70% ROA-20.40% Target Price19.50 Perf Year30.52%
Cash/sh3.03 P/C8.13 EPS next 5Y34.55% ROE-35.40% 52W Range11.47 - 24.88 Perf YTD29.84%
Dividend- P/FCF- EPS past 5Y- ROI-48.30% 52W High-1.00% Beta-
Dividend %- Quick Ratio1.70 Sales past 5Y- Gross Margin73.40% 52W Low114.73% ATR0.93
Employees280 Current Ratio1.90 Sales Q/Q30.20% Oper. Margin-45.90% RSI (14)81.74 Volatility2.09% 3.30%
OptionableYes Debt/Eq0.81 EPS Q/Q74.30% Profit Margin-31.20% Rel Volume1.20 Prev Close24.30
ShortableYes LT Debt/Eq0.60 EarningsNov 01 AMC Payout- Avg Volume323.25K Price24.63
Recom2.70 SMA2032.23% SMA5035.84% SMA20053.09% Volume388,363 Change1.36%
Dec-08-17Downgrade William Blair Outperform → Mkt Perform
May-04-17Downgrade Canaccord Genuity Buy → Hold $22 → $18
Feb-22-17Downgrade BofA/Merrill Buy → Underperform $16
Dec-07-16Initiated Guggenheim Buy $25
Oct-06-16Initiated Deutsche Bank Buy $26
Feb-23-15Initiated Canaccord Genuity Buy $26
Dec-13-17 03:10PM  The Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker Corporation Business Wire
09:44AM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Buffalo Wild Wings, Inc., Aetna, Inc., General Cable Corporation, Sigma Designs, Inc., Entellus Medical, Inc., and Regal Entertainment Group PR Newswire
Dec-11-17 05:15PM  ENTELLUS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entellus Medical, Inc. PR Newswire
Dec-08-17 02:51PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders Business Wire
09:30AM  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entellus Medical, Inc. PR Newswire
08:13AM  Is There Now An Opportunity In Entellus Medical Inc (ENTL)? Simply Wall St.
07:15AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017 Capital Cube
Dec-07-17 04:14PM  ENTELLUS MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire +49.84%
01:39PM  ETFs with exposure to Entellus Medical, Inc. : December 7, 2017 Capital Cube
01:08PM  Why Entellus Medical Inc. Skyrocketed Higher Today Motley Fool
01:00PM  Entellus Medical to be sold to Stryker for $622M American City Business Journals
11:16AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders ENTL Business Wire
08:57AM  Stryker beefs up ENT business with $662 mln Entellus buy Reuters
08:29AM  Stryker to buy Entellus Medical for $662 mln Reuters
08:22AM  Entellus Medical to be acquired by Stryker for $24 a share in cash MarketWatch
08:17AM  Stryker announces definitive agreement to acquire Entellus GlobeNewswire
08:15AM  Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash GlobeNewswire
Nov-21-17 11:41AM  ETFs with exposure to Entellus Medical, Inc. : November 21, 2017 Capital Cube
Nov-14-17 04:05PM  Entellus Medical to Participate in Upcoming Investor Conferences GlobeNewswire
Nov-13-17 10:02AM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 13, 2017 Capital Cube
05:30AM  Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation GlobeNewswire
Nov-10-17 12:20PM  ETFs with exposure to Entellus Medical, Inc. : November 10, 2017 Capital Cube
Nov-02-17 03:35PM  Edited Transcript of ENTL earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-01-17 07:05PM  Entellus reports 3Q loss Associated Press
04:05PM  Entellus Medical Announces Third Quarter 2017 Financial Results GlobeNewswire
09:25AM  Entellus Medical, Inc. to Host Earnings Call ACCESSWIRE
07:35AM  Is Entellus Medical Incs (ENTL) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Oct-30-17 08:30AM  Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox® GlobeNewswire
Oct-18-17 04:05PM  Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017 GlobeNewswire
Oct-17-17 09:41AM  ETFs with exposure to Entellus Medical, Inc. : October 17, 2017 Capital Cube
Oct-06-17 10:49AM  ETFs with exposure to Entellus Medical, Inc. : October 6, 2017 Capital Cube
Oct-05-17 09:36AM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017 Capital Cube
Sep-25-17 08:09AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : September 25, 2017 Capital Cube -5.03%
Sep-14-17 08:19PM  Entellus Medical, Inc. Value Analysis (NASDAQ:ENTL) : September 15, 2017 Capital Cube
Sep-13-17 10:12AM  Entellus Medical, Inc. breached its 50 day moving average in a Bearish Manner : ENTL-US : September 13, 2017 Capital Cube
Aug-11-17 07:56PM  Edited Transcript of ENTL earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 04:03PM  Entellus Medical Announces New Employee Inducement Option Grants GlobeNewswire
Aug-04-17 02:50AM  Entellus reports 2Q loss Associated Press
Aug-03-17 04:03PM  Entellus Medical Announces Second Quarter 2017 Financial Results GlobeNewswire
11:40AM  Investor Network: Entellus Medical, Inc. to Host Earnings Call ACCESSWIRE
Jul-26-17 04:03PM  Entellus Medical to Present at the Canaccord Genuity Annual Growth Conference GlobeNewswire
Jul-20-17 04:30PM  Entellus Medical to Report Second Quarter 2017 Financial Results August 3, 2017 GlobeNewswire
Jul-07-17 12:05PM  [$$] Entellus Medical Agrees to Acquire KKR-Backed Spirox The Wall Street Journal
08:03AM  Entellus Medical Announces Definitive Agreement to Acquire Spirox GlobeNewswire
Jul-03-17 03:10PM  ETFs with exposure to Entellus Medical, Inc. : July 3, 2017 Capital Cube
Jun-19-17 03:16PM  ETFs with exposure to Entellus Medical, Inc. : June 19, 2017 Capital Cube
Jun-08-17 01:34PM  ETFs with exposure to Entellus Medical, Inc. : June 8, 2017 Capital Cube
Jun-06-17 09:23AM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Capital Cube
Jun-01-17 04:03PM  Entellus Medical to Present at the William Blair Growth Stock Conference GlobeNewswire
May-22-17 04:03PM  The Centers for Medicare & Medicaid Services (CMS) Establishes Coding and Payment for Eustachian Tube Balloon Dilation GlobeNewswire
May-04-17 02:02PM  Here's Why Entellus Medical Inc. Stock Is Under the Weather Today Motley Fool -20.51%
May-03-17 05:56PM  Entellus reports 1Q loss Associated Press
04:03PM  Entellus Medical Announces First Quarter 2017 Financial Results GlobeNewswire
08:55AM  Investor Network: Entellus Medical, Inc. to Host Earnings Call Accesswire
Apr-24-17 03:19PM  Entellus Medical, Inc. Value Analysis (NASDAQ:ENTL) : April 24, 2017 Capital Cube
Apr-21-17 08:45AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : April 21, 2017 Capital Cube
Apr-20-17 04:02PM  Entellus Medical to Present at the Deutsche Bank Annual Health Care Conference GlobeNewswire
Apr-19-17 07:00PM  Entellus Medical to Report First Quarter 2017 Financial Results on May 3, 2017 GlobeNewswire
Apr-12-17 04:03PM  Entellus Medical Receives FDA 510(k) Clearance for Eustachian Tube Indication GlobeNewswire
Apr-05-17 04:42PM  ETFs with exposure to Entellus Medical, Inc. : April 5, 2017 Capital Cube
Mar-17-17 09:05AM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 17, 2017 Capital Cube
Mar-10-17 01:36PM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 Capital Cube
Feb-28-17 01:04PM  ENTELLUS MEDICAL INC Financials
Feb-22-17 05:18PM  ENTELLUS MEDICAL INC Files SEC form 10-K, Annual Report -26.81%
08:48AM  Entellus Medical downgraded by BofA/Merrill
Feb-21-17 04:30PM  Entellus Medical Inc Earnings Call scheduled for 4:30 pm ET today
04:24PM  Entellus reports 4Q loss Associated Press
04:07PM  ENTELLUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:03PM  Entellus Medical Announces Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
10:00AM  Moving Average Crossover Alert: Entellus Medical (ENTL) Zacks
07:07AM  Q4 2016 Entellus Medical Inc Earnings Release - After Market Close
Feb-01-17 04:03PM  Entellus Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 21, 2017 GlobeNewswire
Jan-31-17 04:03PM  ENTELLUS MEDICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Jan-27-17 07:51AM  Entellus Medical, Inc. breached its 50 day moving average in a Bearish Manner : ENTL-US : January 27, 2017 Capital Cube
Jan-25-17 09:00PM  Entellus Medical Announces Pricing of Public Offering of Common Stock GlobeNewswire
04:45PM  Entellus Medical Announces Proposed Public Offering of Common Stock GlobeNewswire
04:25PM  ENTELLUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial State
Jan-05-17 04:13PM  ENTELLUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princi
04:03PM  Entellus Medical Announces Management Promotions and Preliminary Revenue for Fourth Quarter and Full Year 2016 GlobeNewswire
Dec-26-16 07:28AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 26, 2016
Dec-13-16 10:33AM  Entellus Medical, Inc. Value Analysis (NASDAQ:ENTL) : December 13, 2016
09:29AM  National Institute for Health and Care Excellence (NICE) Provides Positive Guidance for Use of the XprESS Multi-Sinus Dilation System for Treating Chronic Sinusitis GlobeNewswire
Dec-12-16 07:21AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 12, 2016
Dec-08-16 01:23PM  Heres What Smart Money Thinks of Ryerson Holding Corp (RYI) at Insider Monkey
Nov-29-16 08:47AM  Entellus Medical Announces Publication of Positive Clinical Data for XprESS for Treatment of Pediatric Chronic Rhinosinusitis GlobeNewswire
Nov-22-16 11:46AM  Edited Transcript of ENTL earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-16-16 04:03PM  Entellus Medical to Present at the Piper Jaffray Healthcare Conference GlobeNewswire
Nov-08-16 12:00PM  ETFs with exposure to Entellus Medical, Inc. : November 8, 2016
Nov-07-16 10:58AM  Entellus Medical, Inc. :ENTL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 7, 2016
Nov-04-16 04:39PM  ENTELLUS MEDICAL INC Files SEC form 10-Q, Quarterly Report -10.23%
Nov-03-16 06:29PM  Entellus reports 3Q loss
04:30PM  Entellus Medical Inc Earnings Call scheduled for 4:30 pm ET today
04:25PM  ENTELLUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:03PM  Entellus Medical Announces Third Quarter 2016 Financial Results GlobeNewswire
07:07AM  Q3 2016 Entellus Medical Inc Earnings Release - After Market Close
Nov-01-16 08:15AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : November 1, 2016
Oct-24-16 04:03PM  Entellus Medical to Report Third Quarter 2016 Financial Results on November 3, 2016 GlobeNewswire
Oct-17-16 08:19AM  Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : October 17, 2016
Oct-06-16 09:48AM  ETFs with exposure to Entellus Medical, Inc. : October 6, 2016
Sep-09-16 10:42AM  ETFs with exposure to Entellus Medical, Inc. : September 9, 2016
Entellus Medical, Inc., a medical technology company, focuses on the design, development, and commercialization of products for the minimally invasive treatment of patients suffering from chronic and recurrent sinusitis. The company offers XprESS Multi-Sinus Dilation family of products consisting of XprESS Pro device, XprESS LoProfile device, and XprESS Ultra device, which open an obstructed or narrowed drainage pathway of a sinus cavity by means of trans-nasal balloon sinus dilation. It also provides PathAssist tools, such as LED Light Fiber, a single-use tool that provides real-time high intensity red trans-illumination of the sinus cavity with its battery power; Light Fiber, a single-use tool that provides real-time trans-illumination of the sinus cavity; Light Seeker, a tool with optical fibers embedded into the device to allow ear, nose, and throat (ENT) physicians to access the frontal sinus and trans-illuminate the sinus cavity; Maxillary Seeker, a tool that allow users to find the correct angle to access the natural maxillary ostia; and Sphenoid Seeker/Freer, a two-in-one tool that enables ENT physicians to navigate access to the sphenoid ostium. In addition, the company offers FocESS Sinuscopes that provide ENT physicians with a solution for endoscopic visualization during a sinus procedure; and MiniFESS family of surgical instruments, which include various devices that enable physicians to perform traditional surgical procedures. Further, it distributes surgical navigation systems, components, parts, and related ancillary products to ENT physicians; and XeroGel Nasal Packing Material for use in patients undergoing nasal or sinus surgery, as well as for use as a nasal packing to treat epistaxis or nasal bleeding. The company offers its products through a direct sales force in the United States and United Kingdom, as well as through distributors worldwide. Entellus Medical, Inc. was founded in 2006 and is headquartered in Plymouth, Minnesota.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farley Brian EDirectorDec 07Sale23.85101,3192,416,458291,743Dec 07 04:37 PM
MENSINK KEVIN LVice President, MarketingOct 20Option Exercise1.242,5003,10010,000Oct 24 04:19 PM
MENSINK KEVIN LVice President, MarketingOct 20Sale19.002,50047,5007,500Oct 24 04:19 PM
MENSINK KEVIN LVP MarketingOct 16Option Exercise1.2410,00012,40017,500Oct 18 07:20 PM
MENSINK KEVIN LVP MarketingOct 16Sale18.2910,000182,9037,500Oct 18 07:20 PM
PETERSON KAREN EVP, Regulatory and QualityOct 09Sale20.1765013,11032,734Oct 11 04:08 PM
PETRICK TIMOTHY BVP, Research & DevelopmentOct 04Sale20.012,00040,02692,385Oct 06 04:43 PM
Farley Brian EDirectorOct 04Sale19.9930,000599,709393,062Oct 04 04:43 PM
Farley Brian EDirectorOct 03Sale19.176,028115,527423,062Oct 04 04:43 PM
Farley Brian EDirectorOct 02Sale19.103,97275,865429,090Oct 04 04:43 PM
PETRICK TIMOTHY BVP, Research & DevelopmentSep 22Sale18.002,00036,00094,385Sep 26 04:04 PM
PAIDOSH STEPHEN RVice President, OperationsSep 13Option Exercise1.4025,00035,00032,500Sep 14 04:08 PM
PAIDOSH STEPHEN RVice President, OperationsSep 13Sale17.5425,000438,5007,500Sep 14 04:08 PM
Moen BrentCFO and SecretaryMay 08Buy12.216,10074,47613,600May 08 06:32 PM
Baltzell Joshua JDirectorMay 08Buy12.341,60019,7442,850May 08 06:02 PM
WHITE ROBERT S.President and CEOMay 08Buy12.2410,000122,40055,353May 08 05:49 PM
Essex Woodlands Health Venture10% OwnerJan 31Sale17.00581,5419,886,19791,808Feb 02 04:40 PM
SVLSF IV, LLC10% OwnerJan 31Sale17.00533,0779,062,30910,424Feb 02 04:10 PM
PETERSON KAREN EVP, Regulatory & QualityJan 13Sale20.1310,000201,33133,384Jan 18 04:27 PM
Farley Brian EDirectorJan 13Sale20.1414,019282,319430,562Jan 18 04:12 PM
Farley Brian EDirectorJan 10Sale19.104,84292,483444,581Jan 10 04:43 PM
PETERSON KAREN EVP, Regulatory and QualityJan 10Sale19.104,84092,44443,384Jan 10 04:50 PM
PETERSON KAREN EVP, Regulatory and QualityJan 09Sale19.125,00095,59748,224Jan 10 04:50 PM
Farley Brian EDirectorJan 09Sale19.125,00095,597449,423Jan 10 04:43 PM
Farley Brian EDirectorJan 04Sale19.101583,018454,423Jan 05 04:24 PM
PETERSON KAREN EVP, Regulatory and QualityJan 04Sale19.101603,05643,224Jan 05 04:33 PM
PETERSON KAREN EVP, Regulatory and QualityJan 03Sale18.7410,000187,36643,384Jan 05 04:33 PM
Farley Brian EDirectorJan 03Sale18.7420,000374,728454,581Jan 05 04:24 PM